Parkinson. Parkinson's disease
Conditions
Interventions
Intervention 1: Intervention group: Chamomile capsules (200 mg) will be taken twice a day (morning and night) for 28 consecutive days. The dose of chamomile was considered with the advice of a pharmac
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: No allergies to chamomile or its derivatives Ability to communicate verbally and respond to study tools Dont use anticoagulants (such as heparin, warfarin, aspirin and Plavix) Non-dependence on drugs (including drugs, alcohol, painkillers, antidepressants and hypnotics) No asthma, cancer, insulin-dependent diabetes mellitus and systemic lupus erythematosus, heart failure and mental, hepatic or renal disorders, no use of anticoagulants (heparin, warfarin, aspirin and Plavix), no use of hypnotics And drugs. (Because the capsule used in this study is herbal, it may interfere with drugs with chemical compounds.)
Exclusion criteria
Exclusion criteria: Reluctance of the patient to continue cooperation Non-continuous use of medication as prescribed The occurrence of allergies in the patient The patient should stop consuming chamomile extract for any reason before the end of the intervention period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor function. Timepoint: Before taking the capsules and 28 days after taking the capsules daily. Method of measurement: check list: Short Parkinson's Evaluation Scale/Scales for Outcomes in Parkinson’s Disease – Motor Function. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Before taking the capsules and 28 days after taking the capsules daily. Method of measurement: Quality of Life Questionnaire in Parkinson's Patients (PDQ-39). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Seyed Ali Masoud
Kashan University of Medical Sciences
Outcome results
None listed